|
市場調査レポート
商品コード
1373359
再生医療市場- タイプ別、用途別、世界予測（2023-2032年）Regenerative Medicine Market - By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Global Forecast (2023-2032) |
||||||
カスタマイズ可能
|
|||||||
価格
| 再生医療市場- タイプ別、用途別、世界予測（2023-2032年） |
|
出版日: 2023年09月01日
発行: Global Market Insights Inc.
ページ情報: 英文 100 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
再生医療市場規模は2023年から2032年にかけてCAGR 20.4％で成長します。
世界人口の高齢化は慢性疾患の有病率を高め、再生治療に対する高い需要を生み出しています。また、幹細胞研究、遺伝子治療、組織工学の進歩の高まりは、再生医療をより実行可能で効果的なものにするための治療法の選択肢を世界的に広げています。例えば、2022年1月、ノバルティスは、機能的な肝細胞の再生を刺激する新しい治療法を開発するために、アルニラム社の独自のsiRNA技術を活用するために、アルニラム社と戦略的提携を開始しました。
再生医療における研究開発活動を促進するための投資や資金調達が増加しているのは、規制当局の支援が急増し、承認プロセスが合理化されたためと考えられます。個別化医療の可能性の高まりと、患者とヘルスケア提供者の双方を惹きつけるために、以前は不治の病であった状態の治療への注目度が高まっていることも、業界の拡大に寄与しています。
再生医療産業は、タイプ、用途、地域によって分類されます。
タイプ別では、遺伝子工学技術の進歩や遺伝子治療研究への資金提供の急増により、遺伝子治療分野の産業価値は2032年から2032年にかけて大幅なCAGRで増加すると予測されています。これまで治療不可能であった遺伝性疾患を治療する遺伝子治療の可能性も、同分野の成長を後押しすると思われます。
神経学応用分野は、予測期間中、再生医療市場で大きな収益シェアを占めると予想されています。アルツハイマー病やパーキンソン病などの神経疾患の有病率が上昇していることが、幹細胞を用いた革新的な治療法の開発に道を開いています。加えて、高齢化人口の増加と研究資金の増加が、この分野の成長を後押しします。
地域別では、アジア太平洋地域の再生医療産業は2023年から2032年にかけて堅調なCAGRで拡大すると思われます。この成長の背景には、同地域における高齢化人口の増加とヘルスケアインフラの増加があります。研究開発への投資の増加や政府の有利なイニシアチブの展開も、同地域における再生療法の需要急増に寄与すると思われます。
目次
第1章 調査手法と調査範囲
第2章 エグゼクティブサマリー
第3章 再生医療市場の洞察
- 業界情勢
- 業界への影響要因
- 促進要因
- 世界の慢性疾患の蔓延
- 革新的医薬品開発への投資の増加
- 疾患治療における幹細胞技術の高い採用率
- 潜在的治療薬の強力な製品パイプライン
- 業界の潜在的リスク＆課題
- 厳しい規制の枠組み
- 再生医療治療に伴う高コスト
- 促進要因
- 成長可能性分析
- COVID-19影響分析
- 規制状況
- ポーター分析
- PESTEL分析
第4章 競合情勢
- イントロダクション
- 企業マトリックス分析
- 世界企業シェア分析
- 競合ポジショニングマトリックス
- 戦略ダッシュボード
第5章 再生医療の市場推計・予測：タイプ別、2018年～2032年
- 主要動向：タイプ別
- 細胞治療
- 組織工学
- 遺伝子治療
- その他
第6章 再生医療の市場推計・予測：用途別、2018年～2032年
- 主要動向：用途別
- 腫瘍学
- 筋骨格系
- 神経
- 心血管
- 創傷治癒
- 眼科
- その他の用途
第7章 再生医療の市場推計・予測：地域別、2018年～2032年
- 主要動向：地域別
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- スウェーデン
- オランダ
- その他欧州
- アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- その他ラテンアメリカ
- 中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- その他中東とアフリカ
第8章 企業プロファイル
- Novartis AG
- Amgen Inc.
- Bristol Myers Squibb
- BLUEBIRD BIO
- GC Pharma
- GlaxoSmithKline plc
- ANTEROGEN
- BIOSOLUTIONS
- TERUMO BCT
- AVITA MEDICAL
- Smith and Nephew
- ORGANOGENESIS
図表
Data Tables
- TABLE 1 Product mapping
- TABLE 2 Market revenue, by type (2022)
- TABLE 3 Market revenue, by application (2022)
- TABLE 4 Market share, by region (2022)
- TABLE 5 Global regenerative medicine market size, by region, 2018 - 2022 (USD Million)
- TABLE 6 Global regenerative medicine market size, by region, 2023 - 2032 (USD Million)
- TABLE 7 Global regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 8 Global regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 9 Global regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 10 Global regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 11 Industry impact forces
- TABLE 12 Competitive benchmarking of major market players
- TABLE 13 Competitive positioning matrix: Classification criteria
- TABLE 14 Strategic outlook matrix: Classification criteria
- TABLE 15 Cell therapy market size, by region, 2018 - 2022 (USD Million)
- TABLE 16 Cell therapy market size, by region, 2023 - 2032 (USD Million)
- TABLE 17 Tissue engineering market size, by region, 2018 - 2022 (USD Million)
- TABLE 18 Tissue engineering market size, by region, 2023 - 2032 (USD Million)
- TABLE 19 Gene therapy market size, by region, 2018 - 2022 (USD Million)
- TABLE 20 Gene therapy market size, by region, 2023 - 2032 (USD Million)
- TABLE 21 Other types market size, by region, 2018 - 2022 (USD Million)
- TABLE 22 Other types market size, by region, 2023 - 2032 (USD Million)
- TABLE 23 Oncology market size, by region, 2018 - 2022 (USD Million)
- TABLE 24 Oncology market size, by region, 2023 - 2032 (USD Million)
- TABLE 25 Musculoskeletal market size, by region, 2018 - 2022 (USD Million)
- TABLE 26 Musculoskeletal market size, by region, 2023 - 2032 (USD Million)
- TABLE 27 Neurology market size, by region, 2018 - 2022 (USD Million)
- TABLE 28 Neurology market size, by region, 2023 - 2032 (USD Million)
- TABLE 29 Cardiovascular market size, by region, 2018 - 2022 (USD Million)
- TABLE 30 Cardiovascular market size, by region, 2023 - 2032 (USD Million)
- TABLE 31 Wound healing market size, by region, 2018 - 2022 (USD Million)
- TABLE 32 Wound healing market size, by region, 2023 - 2032 (USD Million)
- TABLE 33 Ophthalmology market size, by region, 2018 - 2022 (USD Million)
- TABLE 34 Ophthalmology market size, by region, 2023 - 2032 (USD Million)
- TABLE 35 Other applications market size, by region, 2018 - 2022 (USD Million)
- TABLE 36 Other applications market size, by region, 2023 - 2032 (USD Million)
- TABLE 37 North America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
- TABLE 38 North America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
- TABLE 39 North America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 40 North America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 41 North America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 42 North America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 43 U.S. regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 44 U.S. regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 45 U.S. regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 46 U.S. regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 47 Canada regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 48 Canada regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 49 Canada regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 50 Canada regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 51 Europe regenerative medicine market size, by country, 2018 - 2022 (USD Million)
- TABLE 52 Europe regenerative medicine market size, by country, 2023 - 2032 (USD Million)
- TABLE 53 Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 54 Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 55 Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 56 Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 57 Germany regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 58 Germany regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 59 Germany regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 60 Germany regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 61 UK regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 62 UK regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 63 UK regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 64 UK regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 65 France regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 66 France regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 67 France regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 68 France regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 69 Spain regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 70 Spain regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 71 Spain regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 72 Spain regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 73 Italy regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 74 Italy regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 75 Italy regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 76 Italy regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 77 Sweden regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 78 Sweden regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 79 Sweden regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 80 Sweden regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 81 The Netherlands regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 82 The Netherlands regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 83 The Netherlands regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 84 The Netherlands regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 85 Rest of Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 86 Rest of Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 87 Rest of Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 88 Rest of Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 89 Asia Pacific regenerative medicine market size, by country, 2018 - 2022 (USD Million)
- TABLE 90 Asia Pacific regenerative medicine market size, by country, 2023 - 2032 (USD Million)
- TABLE 91 Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 92 Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 93 Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 94 Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 95 China regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 96 China regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 97 China regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 98 China regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 99 Japan regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 100 Japan regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 101 Japan regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 102 Japan regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 103 India regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 104 India regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 105 India regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 106 India regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 107 Australia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 108 Australia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 109 Australia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 110 Australia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 111 South Korea regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 112 South Korea regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 113 South Korea regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 114 South Korea regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 115 Rest of Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 116 Rest of Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 117 Rest of Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 118 Rest of Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 119 Latin America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
- TABLE 120 Latin America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
- TABLE 121 Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 122 Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 123 Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 124 Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 125 Brazil regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 126 Brazil regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 127 Brazil regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 128 Brazil regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 129 Mexico regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 130 Mexico regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 131 Mexico regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 132 Mexico regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 133 Argentina regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 134 Argentina regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 135 Argentina regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 136 Argentina regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 137 Rest of Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 138 Rest of Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 139 Rest of Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 140 Rest of Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 141 Middle East & Africa regenerative medicine market size, by country, 2018 - 2022 (USD Million)
- TABLE 142 Middle East & Africa regenerative medicine market size, by country, 2023 - 2032 (USD Million)
- TABLE 143 Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 144 Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 145 Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 146 Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 147 South Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 148 South Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 149 South Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 150 South Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 151 Saudi Arabia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 152 Saudi Arabia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 153 Saudi Arabia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 154 Saudi Arabia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 155 UAE regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 156 UAE regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 157 UAE regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 158 UAE regenerative medicine market size, by application, 2023 - 2032 (USD Million)
- TABLE 159 Rest of Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
- TABLE 160 Rest of Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
- TABLE 161 Rest of Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
- TABLE 162 Rest of Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
Charts & Figures
- FIG 1 GMI report coverage: Critical research elements
- FIG 2 Top-down approach
- FIG 3 Market estimation and forecast methodology
- FIG 4 Market forecasting methodology
- FIG 5 Breakdown of primary participants
- FIG 6 Regenerative medicine industry 36 degree synopsis, 2018 - 2032
- FIG 7 Growth potential analysis, by type
- FIG 8 Growth potential analysis, by application
- FIG 9 Porter's analysis
- FIG 10 PESTEL analysis
- FIG 11 Company matrix analysis, 2022
- FIG 12 Global company market share analysis, 2022
- FIG 13 Competitive positioning matrix, 2022
- FIG 14 Strategic dashboard, 2022
目次
Product Code: 4571
Regenerative medicine market size will grow at 20.4% CAGR from 2023 to 2032. The aging global population is increasing the prevalence of chronic diseases, creating high demand for regenerative therapies. The rising advancements in stem cell research, gene therapy, and tissue engineering are also expanding the availability of treatment options for making regenerative medicine more viable and effective worldwide. For instance, in January 2022, Novartis initiated a strategic partnership with Alnylam to harness the latter's proprietary siRNA technology in a bid to create a new therapy for stimulating the regeneration of functional liver cells.
Increasing investments and funding for expediting research and development activities in regenerative medicine can be attributed to the surging regulatory support and streamlined approval processes. The rising potential for personalized medicine and the higher focus on treating previously incurable conditions for attracting both patients and healthcare providers will also contribute to the industry expansion.
The regenerative medicine industry is categorized based on type, application, and region.
Based on type, the industry value from the gene therapy segment is projected to increase at substantial CAGR from 2032 to 2032, driven by advancements in genetic engineering techniques and the surging funding for gene therapy research. The potential of gene therapy to treat previously untreatable genetic disorders will also push the segment growth.
The neurology application segment is anticipated to account for sizeable revenue share of the regenerative medicine market during the forecast period. The rising prevalence of neurological disorders, such as Alzheimer's and Parkinson's disease is making way for the development of innovative stem cell-based therapies. In addition, the growing aging population and increasing research funding will drive the segment growth.
Regionally, the Asia Pacific regenerative medicine industry will expand at a robust CAGR during 2023-2032. The growth can be attributed to the growing aging population and increasing healthcare infrastructure in the region. The rising investments in research and development and the rollout of favorable government initiatives will also contribute to the burgeoning demand for regenerative therapies in the region.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definition
- 1.2 Base estimates & calculations
- 1.3 Forecast calculation
- 1.4 Covid-19 impact analysis at global level
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Secondary
- 1.6.1.1 Paid sources
- 1.6.1.2 Public sources
- 1.6.2 Primary
- 1.6.1 Secondary
Chapter 2 Executive Summary
- 2.1 Regenerative medicine industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Region trends
- 2.1.3 Type trends
- 2.1.4 Application trends
Chapter 3 Regenerative Medicine Market Insights
- 3.1 Industry landscape, 2018 - 2032 (USD Million)
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing prevalence of chronic diseases worldwide
- 3.2.1.2 Rising investment in development of innovative medicines
- 3.2.1.3 High adoption of stem cell technology in disease treatment
- 3.2.1.4 Strong product pipeline of potential therapies
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Stringent regulatory framework
- 3.2.2.2 High cost associated with some regenerative medicine therapy
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.2 By application
- 3.4 COVID-19 impact analysis
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
- 4.1 Introduction
- 4.2 Company matrix analysis, 2022
- 4.3 Global company market share analysis, 2022
- 4.4 Competitive positioning matrix, 2022
- 4.5 Strategic dashboard, 2022
Chapter 5 Regenerative Medicine Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
- 5.1 Key trends, by type
- 5.2 Cell therapy
- 5.3 Tissue engineering
- 5.4 Gene therapy
- 5.5 Other types
Chapter 6 Regenerative Medicine Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
- 6.1 Key trends, by application
- 6.2 Oncology
- 6.3 Musculoskeletal
- 6.4 Neurology
- 6.5 Cardiovascular
- 6.6 Wound healing
- 6.7 Ophthalmology
- 6.8 Other applications
Chapter 7 Regenerative Medicine Market Estimates and Forecast, By Region, 2018-2032 (USD Million)
- 7.1 Key trends, by region
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Sweden
- 7.3.7 The Netherlands
- 7.3.8 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
- 7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East & Africa
Chapter 8 Company Profiles
- 8.1 Novartis AG
- 8.2 Amgen Inc.
- 8.3 Bristol Myers Squibb
- 8.4 BLUEBIRD BIO
- 8.5 GC Pharma
- 8.6 GlaxoSmithKline plc
- 8.7 ANTEROGEN
- 8.8 BIOSOLUTIONS
- 8.9 TERUMO BCT
- 8.10 AVITA MEDICAL
- 8.11 Smith and Nephew
- 8.12 ORGANOGENESIS
